Question 1

Am I eligible for this trial based on my current health and treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07365332). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07365332). Contact the study team or your healthcare provider for specific answers.

Question 3

How does IKT-001 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07365332). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the study visits and treatments involve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07365332). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07365332). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I do if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) clinical trial (NCT07365332). Contact the study team or your healthcare provider for specific answers.

What this study is about